Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.26 USD | -5.73% | -15.84% | +22.90% |
May. 29 | Transcript : Lantern Pharma Inc. - Special Call | |
May. 24 | Lantern Pharma Files $150 Million Mixed Shelf | MT |
Business Summary
Number of employees: 21
Managers
Managers | Title | Age | Since |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 18-06-30 |
David Margrave
DFI | Director of Finance/CFO | 64 | 18-05-31 |
Reggie Ewesuedo
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-01 |
Kishor Bhatia
CTO | Chief Tech/Sci/R&D Officer | 69 | 19-11-30 |
Ernest Kitt
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 18-06-30 |
Director/Board Member | 73 | 22-06-07 | |
Donald Keyser
CHM | Chairman | 71 | 17-12-31 |
Vijay Chandru
BRD | Director/Board Member | 70 | 19-09-30 |
Director/Board Member | 73 | 18-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,758,805 | 9,171,558 ( 85.25 %) | 0 | 85.25 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.90% | 60.03M | |
+48.17% | 57.87B | |
+41.65% | 40.25B | |
-6.80% | 39.94B | |
-5.96% | 28.54B | |
+12.69% | 26.4B | |
-20.47% | 19.33B | |
+31.22% | 12.4B | |
+0.10% | 12.23B | |
+25.02% | 12.2B |
- Stock Market
- Equities
- LTRN Stock
- Company Lantern Pharma Inc.